Tuesday, 20 December 2016

Allergan to buy Acelity's unit LifeCell for $2.9 billion

(Reuters) - Allergan Plc said it would buy LifeCell, a regenerative medicine unit owned by privately held Acelity LP Inc, for $2.9 billion in cash.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)